EQS-News: Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS
Caroline Jacquin will take over the management of CHEPLAPHARM France, based in Levallois-Perret, a subsidiary of the CHEPLAPHARM Group from Greifswald/Germany, in April 2024.
EQS-News: Cheplapharm AG / Key word(s): Personnel Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS 03.04.2024 / 10:10 CET/CEST The issuer is solely responsible for the content of this announcement. Greifswald / Levallois-Perret, 03. April 2024
Caroline Jacquin will take over the management of CHEPLAPHARM France, based in Levallois-Perret, a subsidiary of the CHEPLAPHARM Group from Greifswald/Germany, in April 2024. The previous Managing Director of CHEPLAPHARM France, Isabelle Dalle, is retiring. Caroline Jacquin, an experienced pharmaceutical manager, is taking over the position of Managing Director of the French subsidiary. Caroline can look back on 25 years of experience in leading positions in different pharmaceutical companies in France, Singapore and Mexico. Most recently, she was Marketing and Sales Director at MSD France, where she was leading the Hospital business unit. The previous Managing Director of CHEPLAPHARM in France, Isabelle Dalle, is taking her well-deserved retirement. She has managed the French subsidiary since its foundation in 2016. Edeltraud Lafer, CEO, thanks Isabelle Dalle (left) for her services and welcomes Caroline Jacquin (right) as the new Managing Director of CHEPLAPHARM France
03.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Cheplapharm AG |
Ziegelhof 24 | |
17489 Greifswald | |
Germany | |
Phone: | 03834 3914 O |
E-mail: | [email protected] |
Internet: | www.cheplapharm.com |
ISIN: | DE000CHP2222 |
WKN: | CHP222 |
EQS News ID: | 1872373 |
Notierung vorgesehen |
End of News | EQS News Service |
|
1872373 03.04.2024 CET/CEST